77.5 F
New York
Saturday, July 31, 2021

MediciNova [NASDAQ: MNOV] Strikes Deal With BioComo And Mie University For SARS-CoV-2 Vaccine Development

Must read

Ucommune [NASDAQ: UK] Ink Cooperation Agreement with Beijing Investment Group

Ucommune International Ltd. inked a cooperation agreement with Beijing Investment Group Co., LTD. Beijing Investment is a fully state-owned land developer associated with...

Lion Electric [NYSE: LEV] all Set to Deliver Two Electric Trucks to Green Mountain Power

The Lion Electric Company revealed on Friday that it is preparing to deliver two of its all-electric trucks to Green Mountain Power (GMP)...

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

MediciNova, Inc. [NASDAQ: MNOV] inked a deal to co-develop the SARS-CoV-2 vaccine with Mie University of Japan & BioComo. MediciNova will develop the COVID-19 vaccine using the human parainfluenza virus type 2 vector, BC-PIV.

BC-PIV is being developed by Mie University & BioComo. BC-PIV has been derived from hPVI2 and it is a non-communicable viral vector. It has the ability to pass on multiple foreign proteins to recipients. BC-PIV is also very safe as no other infectious virus is developed.

It has the ability to carry the large membrane proteins of viruses & signal transduction receptors protein on the surface of the virus. It is developed in a way that it not only display the gene but also exhibits foreign protein itself on the surface & inside the viral membrane.

The SARS-CoV-2 vaccine sample has been created to include the specific SARS-CoV-2 antigen protein in order to show maximum antigenicity. The firm has already got the right to use the BC-PIV for the development of the SARS-CoV-2 vaccine from Mie University & BioComo.

MediciNova, Inc. shares had tumbled 2.08% at $5.64 during the trading of Friday. It had a trading volume of rougly 49k and an average volume of 128.29k. If we look at its profitability, it has return on assets of -14.10%, return on equity of -14.80%.

MediciNova, Inc has recorded the current ratio of 34.60. Likewise, its quick ratio s 34.60. In the past 52-weeks of trading, this company’s stocks has changed between the 52-weeks low of $2.79 and a high of $9.95. It has moved up 102.15% from its 52-weeks low and moved down -43.33% from its 52-weeks high.

President and Chief Executive Officer of MediciNova, Inc, Yuichi Iwaki, M.D., Ph.D. said that the COVID-19 pandemic has spread all around and this is a great opportunity for the company to co-develop the vaccine with BioComo and Mie University.

BioComo had developed the vaccines for Ebola virus and RS virus using the BC-PIV technology. MediciNova is confident that this BC-PIV technology will also be successful in the development of the SARS-CoV-2 vaccine. Furthermore, it is very attractive that a BC-PIV SARS-CoV-2 vaccine can be made as an intranasal formulation.  

More articles

Latest article

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...